Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Feb 15;5(3):841-52.
doi: 10.18632/oncotarget.1780.

Hydrogen peroxide/ATR-Chk2 activation mediates p53 protein stabilization and anti-cancer activity of cheliensisin A in human cancer cells

Affiliations

Hydrogen peroxide/ATR-Chk2 activation mediates p53 protein stabilization and anti-cancer activity of cheliensisin A in human cancer cells

Jingjie Zhang et al. Oncotarget. .

Abstract

Chiliensisine A (Chel A) as a novel styryl-lactone isolated from Goniothalamus cheliensis Hu has been indicated to be a chemotherapeutic agent in Leukemia HL-60 cells. However, its potential for cancer treatment and the underlying mechanisms are not deeply investigated to the best of our knowledge. Current studies showed that Chel A could trigger p53-mediated apoptosis, accompanied with dramatically inhibition of anchorage-independent growth of human colon cancer HCT116 cells. Further studies found that Chel A treatment resulted in p53 protein stabilization and accumulation via the induction of its phosphorylation at Ser20 and Ser15. Moreover, Chel A-induced p53 protein accumulation and activation required ATR/Chk2 axis, which is distinct from the mechanism that we have most recently identified the Chk1/p53-dependent apoptotic response by Chel A in normal mouse epidermal Cl41 cells. In addition, our results demonstrated that hydrogen peroxide generation induced by Chel A acted as a precursor for all these signaling events and downstream biological effects. Taken together, we have identified the Chel A as a new therapeutic agent, which highlights its potential for cancer therapeutic effect.

PubMed Disclaimer

Figures

Fig 1
Fig 1. Chel A inhibited cell viability and anchorage-independent growth via induction of apoptosis in human colon cancer HCT116 cells
(A) HCT116 cells were treated with Chel A for cell proliferation assay as described in “Material and Methods”. After treated for 48 h, cell proliferation was measured by using Cell Titer-GloLuminescent Cell Viability Assay kit. The results are expressed as relative luminescence signal to medium control (proliferation index). Each bar indicates the mean and SD of triplicate assays. The symbol (*) indicates a significant decrease as compared with that of medium control (P<0.05). (B&C) HCT116 cells were exposed to indicate concentrations of Chel A in soft agar as described in Material and Methods. After being cultured in 37°C with 5% CO2 for 3 weeks, the colony formation was observed under inverted microscope and photographed (B). The number of colonies was scored, and presented as colonies per 104 seeded cells (C). The symbol (*) indicates a significant decrease as compared with that of vehicle control (P <0.05). Each bar indicates the mean and SD from three independent experiments. (D-F) HCT116 cells (D & E) or U5637 cells (F) were cultured in each well of a six-well plate with McCoy's 5A medium containing 10% FBS at 37°C overnight. After synchronization of cells by culturing in McCoy's 5A medium containing 0.1% FBS for 24 hours, the cells were treated with various concentrations Chel A as indicated, for 48 hours (D) or with 4.0 ¼M Chel A for indicated time periods (E) or for 36 hrs (F). The cells as indiacted were collected and subjected to flow cytometry assay (D) and Western blot assay (E & F). The result was representative one from three independent experiments.
Fig 2
Fig 2. p53 induction mediated Chel A-induced apoptosis
(A) HCT116 cells were treated with Chel A for indicated time periods and cell extracts were subjected to Western blotting for the detection of phosphorylated and total p53 protein expression. β-Actin was used as a control for protein loading. (B&C) HCT116 p53+/+ and p53−/− cells were seeded into six-well plates. The cells were treated with Chel A for 48 hrs and then subjected to flow cytometry assay (B) or treated with Chel A for 48 hrs and then subjected to Western blotting to determine the expression and cleavages of PARP and Caspase 3. β-Actin was used as a control for protein loading (C). The result showing was a representative one from three independent experiments. (D&E) HCT116 p53+/+ and p53−/− cells were exposed to indicate concentrations of Chel A in soft agar as described in Material and Methods. After being cultured in 37℃ with 5% CO2 for 3 weeks, the colony formation was observed under inverted microscope and photographed (D). The relative colony formation was presented as the colony in Chel A-treated group relative to the vehicle control in HCT116 p53+/+ and p53−/− cells, respectively (E). The symbol (*) indicates a significant increase in HCT116 p53−/− cells with treatment of Chel A as compared with that in HCT116 p53+/+ cells treated with Chel A (p <0.05). Each bar indicates the mean±SD of three independent experiments.
Fig 3
Fig 3. p53 protein induction by Chel A was via the inhibition of p53 protein degradation
(A) HCT116 cells were treated with Chel A for indicated time periods, and p53 mRNA was measured by RT-PCR. (B) HCT116 cells were pretreated with MG132 for 4 hrs, followed by exposure with CHX combined with Chel A or CHX alone as indicated. Then cell extracts were subjected to Western Blotting and β-Actin protein expression was used as a protein loading control. (C) HCT116 cells were exposed to Chel A for indicated time periods, and cell extracts were subjected to Western Blotting and β-Actin protein expression was used as a protein loading control. (D) HCT116 cells were treated with Chel A for indicated time periods, and ATR mRNA was evaluated by RT-PCR.
Fig 4
Fig 4. Chk2 mediated the biological effect of Chel A in HCT116 cells
(A) HCT116 Chk2−/− cells and its parental wild type cells were treated with Chel A as indicated, and the cell extracts were subjected to Western Blotting for determination of the protein expressions using specific antibodies. β-Actin was used as protein loading controls. (B) HCT116 Chk2−/− and its parental wild type cells were pretreated with MG132 for 4 hrs, followed by exposure with CHX combined with Chel A or CHX alone as indicated. Then cell extracts were subjected to Western Blotting and β-Actin protein expression was used as a protein loading control. (C&D) HCT116 Chk2+/+ and Chk2−/− cells were treated with Chel A (4.0 ¼M) for 48 hrs. Cells were then collected for flow cytometry assay (C) or subjected to Western blotting as indicated (D). The result showing was a representative one from three independent experiments. (E&F) HCT116 Chk2+/+ and Chk2−/− cells were exposed to indicate concentrations of Chel A in soft agar. After being cultured in 37°C with 5% CO2 for 3 weeks, the colony formation was observed under inverted microscope and photographed (E). The relative colony formation was presented as the colony in Chel A-treated group relative to the vehicle control in HCT116 Chk2+/+ and Chk2−/− cells, respectively (F). The symbol (*) indicates a significant increase in HCT116 Chk2−/− cells with Chel A treatment as compared with that in HCT116 Chk2+/+ cells treated with Chel A (P<0.05). Each bar indicates the mean±SD of three independent experiments
Fig 5
Fig 5. ATR conditional knockout attenuated the biological effect of Chel A in HCT116 cells
(A) HCT116 ATR flox/− cells and its parental wild type cells were treated with Chel A as indicated, and the cell extracts were subjected to Western blotting for determination of the protein expressions using specific antibosies. β-Actin was used as protein loading controls. (B&C) HCT116 ATR flox/- and wild type cells were were treated with Chel A for 48 hrs. The cells were then collected and subjected to flow cytometry analysis (B), or subjected to Western blotting(C). The result showing was a representative one from three independent experiments. (D&E), HCT116 ATR flox/- and its parental wild type cells were exposed to indicated concentrations of Chel A in soft agar. After being cultured in 37°C with 5% CO2 for 3 weeks, the colony formation was observed under inverted microscope and photographed (D). The relative colony formation was presented as the colony in Chel A-treated group relative to the vehicle control in HCT116 ATR+/+ and ATR flox/- cells, respectively (E). The symbol (*) indicates a significant increase in HCT116 ATR flox/- cells with Chel A treatment as compared with that in HCT116 cells treated with Chel A (P<0.05). Each bar indicates the mean±SD of three independent experiments.
Fig 6
Fig 6. mCat overexpression blocked the biological effect of Chel A-induced hydrogen peroxide in HCT116 cells
(A&B) HCT116 cells were pretreated with 2',7'-dichlorfluorescein-diacetate (DCFH) (A) ordihydroethidium (HE) (B), respectively, for 0.5 hr, followed by being treated with Chel A for indicated time periods. Then cells were washed with PBS, and subjected to fluorescence intensity detection. The results were shown as the induction of each time point relative to 0 h(Relative fluorescence intensity). The symbol (*) indicates a significant increase as compared with that at 0 h (P <0.05). Each bar indicates the mean±SD from three independent experiments. (C&D) HCT116 mCat and its parental HCT116 (vector) cells were treated with Chel A for 0-6 hrs, and the cell extracts were subjected to Western blotting. β-Actin was used as protein loading controls. (E&F) HCT116 mCat and HCT116 (vector) cells were treated with indicated concentrations of Chel A in soft agar. After being cultured in 37°C with 5% CO2 for 3 weeks, the colony formation was observed under inverted microscope and photographed (E). The relative colony formation was presented as the colony in Chel A-treated group compared with vehicle control in HCT116 mCat and HCT116 (vector) cells, respectively (F). The symbol (*) indicates a significant increase in HCT116 mCat cells treated with Chel A as compared with that of HCT116 (vector) cells treated with Chel A (p <0.05). Each bar indicates the mean±SD of three independent experiments. (G)The diagram indicates mechanisms responsible for Chel A-induced apoptosis in HCT116 cells.

Similar articles

Cited by

References

    1. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ. Cancer statistics, 2005. CA Cancer J Clin. 2005;55:10–30. - PubMed
    1. Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res. 2006;69:562–573. - PubMed
    1. Tachibana M, Kawamata H, Fujimori T, Omotehara F, Horiuchi H, Ohkura Y, Igarashi S, Kotake K, Kubota K. Dysfunction of p53 pathway in human colorectal cancer: analysis of p53 gene mutation and the expression of the p53-associated factors p14ARF, p33ING1, p21WAF1 and MDM2. Int J Oncol. 2004;25:913–920. - PubMed
    1. Li CM MQ, Sun HD, Xu B, Tang WD, Zheng HL, et al. A new anti-cancer constituent of Goniothalamus cheliensis. Acta Botanica Yunnanica. 1998;20:102–104.
    1. Zhong L, Li CM, Hao XJ, Lou LG. Induction of leukemia cell apoptosis by cheliensisin A involves down-regulation of Bcl-2 expression. Acta Pharmacol Sin. 2005;26:623–628. - PubMed

Publication types

MeSH terms